Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

Qureight, an end-to-end imaging CRO providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced it has been selected by Celea Therapeutics as the…

Continue ReadingQureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

All-in-One solution for continuous microbial monitoring without production interruptions

Particle Measuring Systems (PMS), a global leader in contamination monitoring solutions, today announced the launch of the BioCapt® Single-Use STS Microbial Monitor, a sterile transfer solution that enables the introduction…

Continue ReadingAll-in-One solution for continuous microbial monitoring without production interruptions